🇺🇸 FDA

Drug profile · INN

dasatinib

DASATINIB ACCORD HEALTHCARE

approved L01EA02
US status
approved
Patents linked
2
News articles
0

Quick answer

dasatinib (DASATINIB ACCORD HEALTHCARE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN dasatinib
Brand DASATINIB ACCORD HEALTHCARE
Route ORAL
Formulation TABLET
ATC code L01EA02
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 8067423

    Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7973045

    Anhydrous form of dasatinib and process for preparation thereof

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is dasatinib?

dasatinib (DASATINIB ACCORD HEALTHCARE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for dasatinib?

DASATINIB ACCORD HEALTHCARE is a marketed brand name for dasatinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dasatinib?

dasatinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.